Deutsche Bank
AGL icon

Deutsche Bank’s Agilon Health AGL Stock Holding History

Deutsche Bank’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
13,181
+3,172
+32% +$208K ﹤0.01% 2115
2026
Q1 		$79.2K Sell
10,009
-18,040
-64% -$292K ﹤0.01% 3351
2025
Q4 		$484K Sell
28,049
-1,306
-4% -$25.3K ﹤0.01% 2587
2025
Q3 		$756K Sell
29,355
-8,660
-23% -$327K ﹤0.01% 2329
2025
Q2 		$2.19M Sell
38,015
-9,416
-20% -$755K ﹤0.01% 1650
2025
Q1 		$5.13M Sell
47,431
-770
-2% -$67K ﹤0.01% 1244
2024
Q4 		$2.29M Sell
48,201
-35,296
-42% -$2.13M ﹤0.01% 1764
2024
Q3 		$8.2M Buy
83,497
+9,561
+13% +$1.23M ﹤0.01% 1081
2024
Q2 		$12.1M Buy
73,936
+21,856
+42% +$3.11M 0.01% 947
2024
Q1 		$7.94M Sell
52,080
-2,413
-4% -$401K ﹤0.01% 1105
2023
Q4 		$17.1M Buy
54,493
+726
+1% +$263K 0.01% 834
2023
Q3 		$23.9M Sell
53,767
-826
-2% -$373K 0.02% 661
2023
Q2 		$23.7M Buy
54,593
+6,667
+14% +$3.75M 0.01% 722
2023
Q1 		$28.5M Buy
47,926
+7,906
+20% +$4.43M 0.02% 666
2022
Q4 		$16.1M Sell
40,020
-10,949
-21% -$5.13M 0.01% 818
2022
Q3 		$29.8M Buy
50,969
+10,974
+27% +$6.57M 0.02% 651
2022
Q2 		$21.8M Sell
39,995
-4,566
-10% -$2.31M 0.01% 764
2022
Q1 		$28.2M Sell
44,561
-3,872
-8% -$2M 0.01% 748
2021
Q4 		$32.7M Buy
48,433
+5,753
+13% +$3.5M 0.01% 714
2021
Q3 		$28M Buy
42,680
+36,840
+631% +$31.5M 0.01% 780
2021
Q2 		$5.92M Buy
+5,840
New +$5.12M ﹤0.01% 1423

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Deutsche Bank's AGL Position: Q2 2026 in Review

Deutsche Bank increased its Agilon Health (AGL) stake by 32% in Q2 2026, buying an estimated $208K and bringing the position to 13,181 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Deutsche Bank first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $32.7M in Q4 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Deutsche Bank held 13,181 shares of Agilon Health worth $1.41M as of Q2 2026.
  • Deutsche Bank bought 3,172 Agilon Health shares in Q2 2026, an estimated $208K.
  • Agilon Health made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2115 holding.
  • Deutsche Bank first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Deutsche Bank's Agilon Health position peaked at $32.7M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.